Juan Liu

Researcher Next ID · RN-024690

Researcher · Biochemistry, Genetics and Molecular Biology

Chengdu, Estonia

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Cancer-related molecular mechanisms research

Circular RNAs in diseases

MicroRNA in disease regulation

RNA modifications and cancer

RNA Research and Splicing

IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC).
Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.2021.39.3_suppl.267
CCR7 Chemokine Receptor-Inducible lnc-Dpf3 Restrains Dendritic Cell Migration by Inhibiting HIF-1α-Mediated Glycolysis
Immunity · 2019 · https://doi.org/10.1016/j.immuni.2019.01.021
Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review
Journal of Autoimmunity · 2017 · https://doi.org/10.1016/j.jaut.2017.03.008
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Nature · 2015 · https://doi.org/10.1038/nature15252

No projects listed.